Latin America Pharmaceutical Contract Manufacturing Services Market Worth USD 21 Billion By 2025: Grand View Research, Inc.

The Latin American pharmaceutical contract manufacturing services market is anticipated to reach USD 21.0 billion by 2025, according to a new report by Grand View Research, Inc. Low drug registration cost in Latin American countries and continuous economic growth are the key factors contributing to progress in this region. Moreover, Latin America offers higher recruitment rates and relatively high competitive prices in comparison to United States and other European countries.

A forementioned fact pronounces the trend of shifting Contract Manufacturing/Research Organizations (CMO/CRO)’s attention to Latin American countries such as Brazil, Mexico, Argentina, and Colombia. Ongoing adjustment in Latin America to reduce the commodity prices and domestic political turbulence in each country is expected to shape region’s economic growth there by driving revenue generation in the outsourcing market for pharmaceutical development.

Browse full research report on Latin America Pharmaceutical Contract Manufacturing Services Market: http://www.grandviewresearch.com/industry-analysis/latin-america-pharmaceutical-contract-manufacturing-services-market

Further Key Findings from the study suggest:

  • Contract manufacturing services accounted for the largest share owing to wide range of services offered by the CMO’s located herein for therapeutic drug development
  • API/Bulk drug development services accounted for the largest share over the other segments as companies continue to invest for API production capacity enhancement
  • Rising inclination of drug manufacturers to focus on core competencies such as R&D are observed to have a major impact on the yearly growth of contract research organizations
  • Brazil held the largest share with respect to revenue generation in 2015
  • Government’s current initiative to ensure GMP compliance among small and medium-sized pharma companies has contributed for the large share of Brazil
  • Chile is expected to witness the fastest growth over the forecast period.
  • Presence of companies offering bioanalytical, biomarker discovery, assay development, and cGMP analytical services can be attributed for the estimated growth
  • Key players contributing in this market are Lonza; Charles River Laboratories S.A; Jubilant Life Sciences Limited; Boehringer Ingelheim GmbH; Pfizer, Inc. (Pfizer CenterOne); Albany Molecular Research, Inc; QuintilesIMS; and Pharmaceutical Product Development, LLC.
  • These entities are involved in collaborations with therapeutic research organizations in order to enhance their industrial presence
 Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Latin America pharmaceutical contract manufacturing services market on the basis of services and country:

Latin America Pharmaceutical Contract Manufacturing Service Outlook (Revenue, USD Million, 2014 - 2025)
  • Manufacturing
    • API/Bulk Drugs
    • Advanced Drug Delivery Formulations Packaging
    • Packaging
    • Finished Dose Formulations
    • Solid Formulations
    • Liquid Formulations
    • Semi-solid Formulations
  • Research
    • Oncology
    • Vaccines
    • Inflammation & Immunology
    • Cardiology
    • Neuroscience
    • Others
Latin America Pharmaceutical Contract Manufacturing Service Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • Brazil
  • Mexico
  • Colombia
  • Argentina
  • Chile
  • Venezuela
  • Rest of Latin America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com




Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.